LDDD Stock Overview
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Longduoduo Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.37 |
| 52 Week High | US$109.00 |
| 52 Week Low | US$2.01 |
| Beta | 0 |
| 1 Month Change | 2.29% |
| 3 Month Change | 3.47% |
| 1 Year Change | -93.19% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| LDDD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.6% | 0.6% | 1.0% |
| 1Y | -93.2% | 2.2% | 21.9% |
Return vs Industry: LDDD underperformed the US Healthcare industry which returned 3.4% over the past year.
Return vs Market: LDDD underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| LDDD volatility | |
|---|---|
| LDDD Average Weekly Movement | 13.7% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LDDD's share price has been volatile over the past 3 months.
Volatility Over Time: LDDD's weekly volatility has decreased from 38% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 65 | Hongxiao Zhou | www.longduoduo.net |
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China. It offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers. The company was founded in 2020 and is headquartered in Hohhot, China.
Longduoduo Company Limited Fundamentals Summary
| LDDD fundamental statistics | |
|---|---|
| Market cap | US$161.13m |
| Earnings (TTM) | US$831.39k |
| Revenue (TTM) | US$7.27m |
193.8x
P/E Ratio22.2x
P/S RatioIs LDDD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LDDD income statement (TTM) | |
|---|---|
| Revenue | US$7.27m |
| Cost of Revenue | US$515.37k |
| Gross Profit | US$6.75m |
| Other Expenses | US$5.92m |
| Earnings | US$831.39k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.028 |
| Gross Margin | 92.91% |
| Net Profit Margin | 11.44% |
| Debt/Equity Ratio | 0% |
How did LDDD perform over the long term?
See historical performance and comparison